Preliminary Examination of the Reliability and Concurrent Validity of the Attention-Deficit/Hyperactivity Disorder Self-Report Scale v1.1 Symptom Checklist to Rate Symptoms of Attention-Deficit/Hyperactivity Disorder in Adolescents

被引：75

作者：

Adler, Lenard A. ^{[1
,2
,3
]}

Shaw, David M. ^{[1
]}

Spencer, Thomas J. ^{[4
,5
]}

Newcorn, Jeffrey H. ^{[6
]}

Hammerness, Paul ^{[5
]}

Sitt, David J. ^{[7
]}

Minerly, Christina ^{[8
]}

Davidow, Jennifer V. ^{[6
]}

Faraone, Stephen V. ^{[9
,10
]}

机构：

[1] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA

[2] NYU, Sch Med, Dept Child & Adolescent Psychiat, New York, NY 10016 USA

[3] VA New York Harbor Healthcare Syst, Psychiat Serv, New York, NY USA

[4] Harvard Univ, Sch Med, Dept Psychiat, New York, NY USA

[5] Massachusetts Gen Hosp, Pediat Psychopharmacol Res Program, Boston, MA 02114 USA

[6] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA

[7] CUNY, Baruch Coll, Dept Psychol, New York, NY 10021 USA

[8] CUNY Hunter Coll, Dept Psychol, New York, NY 10021 USA

[9] SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY USA

[10] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY USA

来源：

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY | 2012年 / 22卷 / 03期

基金：

美国国家卫生研究院;

关键词：

DEFICIT HYPERACTIVITY DISORDER; ONCE-DAILY ATOMOXETINE; LISDEXAMFETAMINE DIMESYLATE; DOUBLE-BLIND; ADULT ADHD; CHILDREN; COMORBIDITY; TOLERABILITY; DIAGNOSIS; PATTERNS;

D O I：

10.1089/cap.2011.0062

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Objective: To validate the attention-deficit/hyperactivity disorder (ADHD) Self-Report Scale (ASRS) v1.1 Symptom Checklist versus the clinician-administered ADHD Rating Scale (ADHD-RS) in adolescents with ADHD. Method: A total of 88 adolescents with ADHD aged 13-17 years participated in the study. The study was completed in one or two visits, 1-9 weeks apart. At each visit, participants completed the ASRS v1.1 Symptom Checklist, after which raters administered the ADHD-RS. Internal consistency of the ASRS v1.1 Symptom Checklist was assessed by Cronbach's alpha (Cronbach's a). Concurrent validity between the scales was assessed using Pearson's correlation coefficients. Item-by-item reliability between the scales was assessed by the Kappa coefficient of agreement. Results: The mean age of participants was 14.9 +/- 1.5 SD years. 76.1% (n = 67) were male. 73.9% (n = 65) were currently receiving medication for ADHD. Internal consistency of ASRS v1.1 Symptom Checklist items was high, with Cronbach's a coefficients of 0.93 at Visit 1 and 0.94 at Visit 2. Pearson's correlation coefficients between the ASRS v1.1 Symptom Checklist and ADHD-RS were highly significant at Visit 1 (r = 0.72, p < 0.0001) and Visit 2 (r = 0.73, p < 0.0001). There was moderate item-by-item agreement between individual items on the scales (% agreement: 35.2%-63.4%) with statistically significant kappa coefficients for 17 of the 18 items. Conclusion: The ASRS v1.1 Symptoms Checklist showed high internal consistency and high concurrent validity with the clinician-administered ADHD-RS in adolescents with ADHD. Results of this study suggest that the ASRS v1.1 Symptom Checklist is an internally consistent self-report scale for the assessment of adolescent ADHD and is moderately associated with a concurrently administered clinician measure of ADHD symptoms.

引用

页码：238 / 244

页数：7

共 38 条

[1] Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder [J].